We have all the latest available treatments, which are used according to each patient´s requirements.

We are pioneering carrying out and follow-up care for these treatments, and forerunners in the realisation of some of them in particular, such as hepatic transplants and radioembolisation with Yttrium-90 microspheres.

We offer high quality surgical, medical and follow-up care for our patients who undergo liver transplants. This allows us to diagnose any possible complications early on to increase the patients´ survival rate. The Clínica has a 90% survival rate for liver transplant patients one year after they undergo surgery. 


Imagen con los pasos que hay que dar para solicitar una segunda opinión en la Clínica Universidad de Navarra

If you require the opinion of our experts without having to travel to the Clinica, we offer the possibility of a Second Medical Opinion consultation.

Hepatic arterial embolization for the treatment of hepatic tumours has a high survival rate and could cure the patient of their disease.

This treatment is limited to the liver and is very selective. It is based on the peculiar occurrence that for hepatic tumours, blood only arrives through the hepatic artery, whilst for the liver itself, the same amount of blood, if not more, comes from the portal vein, not just the hepatic vein.

As a result, this treatment consists in injecting the hepatic artery, as selectively as possible, with some tiny plastic spheres that obstruct the small blood vessels. The result is that the tumour (or tumours) is left without a bloodstream to sustain them, whilst the portal vein is responsible for supplying the healthy liver with blood.

The treatment is usually repeated every six weeks, as many times as necessary, but this is normally three or four times.

Although the treatment doesn´t require an operating theatre or anaesthetic, it usually requires a prolonged hospitalisation period of 2-4 days, this is the necessary time for controlling any secondary effects that could arise: pain, nausea, fever.

Rarely, complications such as the infection of the tumour or hepatic insufficiency can occur. Hepatic embolization is a treatment that can be used when surgery or radiofrequency are not possible.

This treatment gives the patient a better survival rate, and in some cases, can cure them of their condition. This can only be used when the patient´s hepatic function is good. 

Partial spleen embolization stops part of the spleen from functioning.

This treatment injects substances into the splenic artery that stop the passage of blood, and therefore stops 75% of the spleen from functioning.

This is carried out to benefit the organism, by reducing the efficient volume of the spleen, there are more elements of the blood, such as white blood cells, leukocytes and platelets, available which would normally accumulate inside the spleen. Therefore, greater quantities of these elements circulate in the organism and can be effective in other areas of the body where they are necessary.

Benefits of arterial spleen embolization:

  1. The treatment is carried out with drugs which reduce the levels of white blood cells and platelets. Amongst these, there are some which have a chemotherapeutic effect against cancer and interferon, which are used to treat hepatitis C and B viruses.
  2. When the number of platelets is very low, the surgeons can carry out (non-urgent) selective surgical operations more safely, and clots are less likely to occur.

A genetic study used for both disease prevention and treatment.

The latest big advances in genetics and molecular biology has meant that more and more specific techniques have been developed for the detection of genetic changes that will help in the precise diagnosis of some hereditary hepatic diseases.

Determining these genetic changes allows for diagnosis in family members who are likely to also develop the illness, and they can then proceed to have early preventative treatment.

Amongst the diseases that can be prevented, there is a possibility of detecting genetic changes in 90% of hemochromatosis cases. Also, specialists can determine these changes in other more common processes, such as alpha-1- antitrypsin deficiency (the most common genetic hepatic disease in children), Wilson´s disease (which causes hepatic and neurological diseases) or familial intrahepatic cholestasis, which leads to cirrhosis of the liver and gall bladder stones (biliary lithiasis).

The Genetics Unit at the Clínica is responsible for carrying out this type of diagnostic test and has vast experience and the most advanced technology. 

Hepatic radiofrequency, safely, burns the hepatic tumours.

Hepatic radiofrequency is a simple and safe therapeutic technique, which is very well tolerated by patients. Intense heat is applied onto hepatic tumours, whether they are primary or secondary (hepatic metastasis).

To transmit the intense heat to the tumours, some needles which are also electrodes and transmit energy are used. These needles are inserted into the liver through the skin, and this procedure doesn´t require general anaesthetic but deep sedation may be used for less patient discomfort.

The needs are inserted into the tumours guided by ultrasound to hit the target area and, once embedded, the energy that generates the heat is applied for a few minutes on the tissue surrounding the needle, up to a maximum diameter of around 5cm. As a result, this treatment is only used on tumours which are smaller than 5cm and must not be carried out if a blood vessel or bile duct is in the heat radius because it will burn them.

When tumours are not visible in ultrasound or when there are various which require a prolonged procedure, the treatment can be carried out as open surgery or laparoscopically.

Generally, the hospitalisation period is 24 hours and, although it´s rather uncommon, after being discharged patients may feel some pain or have a mild fever for a few days. 

Hepatic radioembolisation is a new treatment for inoperable tumours.

Radioembolisation is a new treatment for both primary (hepatocarcinoma) and secondary (hepatic metastasis) inoperable hepatic tumours.

Radiation is administered directly onto the tumour, avoiding the healthy liver tissue. This radiation emits some microscopic radioactive spheres which are charged with Yttrium-90. This element emits limited penetration radiation.

One of the defining characteristics of the Clínica is the constant research and development into new technologies in the fight against cancer. One of these techniques is hepatic radioembolisation for which the Clínica is a European reference centre with more than 300 treatments successfully carried out.

La radioembolización es un tratamiento novedoso para los tumores hepáticos no operables. Consiste en la administración en la arteria hepática a través de un catéter de unas esferas microscópicas cargadas de Ytrio-90, un elemento emisor de radiación de escasa penetración. La radiación que emiten estas microesferas ataca lentamente al tumor,  respetando el hígado sano.
Radioembolisation is a novel treatment for inoperable liver tumors. [Video only available in Spanish]

Hepatic resection is the procedure of choice for patients affected by primary or secondary tumours located in the liver.

The survival rate after hepatic resection has notably increased, due to the improved results in this oncological treatment and the specialists´ recommendations for using this technique.

In primary liver tumours it can be carried out whilst conserving hepatic function. 

A hepatic transplant is the only therapeutic treatment for serious diseases.

The affected liver is removed and substituted by a healthy organ from either a deceased or living donor; this may the complete organ or just a section.

It is the only therapeutic treatment for a wide variety of serious diseases, such as advanced cirrhosis, some tumours, congenital hepatic anomalies or metabolic conditions causing liver deficiencies.

Hepatic transplant results at the Clínica are very good; the survival rate one year after the operation is over 90%, approximately 80% after 5 years, and 65% after 10. 

Historia de una hija que donó parte de su hígado a su madre. A pesar de que España es el país del mundo con mayor índice de donaciones de órganos, el número de receptores supera al de donantes. Por esta  razón, en los últimos años se vienen realizando trasplantes hepáticos de donante vivo,  en los que se extirpa una parte del hígado del donante (generalmente  será un familiar del receptor) y se le implanta al enfermo.
Living donor liver transplantation, story of a daughter who donated part of his liver to his mother. [Vídeo only available in Spanish]

you maybe interested


Learn why the Clínica Universidad de Navarra is different from other hospitals.

Imagen de una niña pequeña con cáncer por los pasillos de la Clínica


Want to participate in our clinical trials? Learn which ones are active.

Imagen médico investigando con microscopio


Know what we do for our international patients

Entrada principal a la Clínica Universidad de Navarra